NVIDIA AI Podcast How Agentic AI Shortens Drug Development and Boosts Patient Outcomes - Ep. 277
58 snips
Oct 15, 2025 Avinob Roy and Raja Shankar from IQVIA dive into the revolutionary potential of agentic AI in pharmaceuticals. They discuss how intelligent automation can drastically shorten clinical trials, enhance commercialization strategies, and lead to better patient care. The duo highlights the importance of optimizing treatment choices and personalizing patient engagement through data-driven insights. Additionally, they touch on the challenges of data security and the need for effective performance measurement to ensure successful AI application in healthcare.
AI Snips
Chapters
Transcript
Episode notes
Simulate Trials And Automate Repetitive Tasks
- Two major opportunities are clinical development simulation and clinical trial automation with agents.
- Simulating trials and automating repetitive tasks can raise success rates and cut trial time and cost.
Agents Tame Commercial Data Chaos
- Commercial teams face data chaos from many sources, and agents can stitch heterogeneous data to speed decisions.
- Agents help strategy, operationalization, and engagement so launches reach the right patients faster.
The Real Problem Is Data Integration
- Life sciences rarely lack raw data; their challenge is connecting and preparing disparate sources for use.
- IQVIA research found executives see data integration, not data scarcity, as the primary AI barrier.